From evaluation studies to executable plans, early decisions define long-term success.

Next-generation cell and gene therapies now.

In today’s advanced therapies market, progress depends on making the right decisions early — before capital is committed and timelines are locked.

Whether you’re evaluating modalities, assessing manufacturing strategies, or pressure-testing costs and schedules, success begins with clear, grounded plans that align with your science and your business case.

CRB partners with advanced therapy innovators to move programs forward with confidence, starting where the industry is today.

Our services include:

  • Facility test fits and manufacturing option analysis
  • Flexible layout development and space planning
  • Dynamic simulation, operational modeling, and debottlenecking
  • Biocontainment, isolation strategies, and ATMP safety systems
  • IV bag and custom fill-finish equipment integration
  • GMP design reviews, gap assessments, and inspection readiness
  • Value engineering, cost optimization, and FDA pre-construction support

 

 Expert Perspectives on Cell and Gene Therapy 

Horizons LS25 Report Spreads Mockup (TEST)
The 2025 Horizons: Life Sciences report
From bold process strategies to groundbreaking modalities, discover how science, execution, and human drive are converging to shape the future.
ATMP
An introduction to ATMP manufacturing
ATMPs are transforming medicine, presenting major opportunities and challenges. Here's a look at how manufacturers are navigating a rapidly evolving industry.
Chasing Workstations Cell Therapy Workflow Graphic_Video Preview
Cell therapy manufacturing process: how to design your facility
When it comes to the cell therapy manufacturing process, how you design the facility is integral to the success of commercial-scale manufacturing.

Advanced Therapies in Action

See how CRB supports cell & gene therapy programs across the lifecycle—from early concept through commercial readiness.

Ultragenyx
Umoja Bio
Gene therapy facility to bring novel products to market for treatment of rare diseases
Ultragenyx Pharmaceutical | Bedford, MA
Flexible ATMP facility designed to reflect company culture with integrated approach
Umoja Biopharma, Inc. | Louisville, CO

What We're Seeing in Cell and Gene Therapy Manufacturing

Viral Vector
How to achieve a viral vector manufacturing facility at scale
Cell Therapy_700x408
4 cell therapy manufacturing approaches: your guide to optimizing every square foot
Cell and Gene Site Selection_700x408
Select the best site for your cell and gene therapy facility in three steps
Peter-cell-light blue

Peter Walters

Fellow, Advanced Therapies 

Connect with Our Team

Learn more about how CRB helps our clients evaluate options, reduce risk, and build operationally sound paths to market.

Let’s optimize your process, together.